Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and ...

The Conference on Retroviruses and Opportunistic Infections 2025 (CROI) featured multiple sessions that focused on breaking research and treatments.

In 2020, the Conference on Retroviruses and Opportunistic Infections (CROI) was the first scientific conference to move from ...

Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from a study presented at the Conference on Retroviruses and Opportunistic ...

Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant ...

News reporting will resume with coverage of the Conference on Retroviruses and Opportunistic Infections (CROI), being held in San Francisco from 9 to 12 March. Our reporting team from CROI are Keith ...

A total of 9% of placebo recipients contracted COVID-19 from a household member, compared with 2.9% of ensitrelvir recipients ...

Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

As scientists gathered at the Conference for Retroviruses and Opportunistic Infections, or CROI, for meetings that run through Wednesday, they face an uncertain future. It was evident in who was ...

At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full day of the conference, reports from the ...

The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close ...

Detailed results were presented at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco. ...